Sun Pharmaceutical Industries Limited

This study looks at the long-term safety and effectiveness of tildrakizumab in people with psoriatic arthritis, a condition causing joint pain and skin patches. About 529 adults who completed a prior study will receive the drug and be monitored for side effects and symptom improv…

This study tests whether a cream called clascoterone (Winlevi) can shrink oil glands and change the oil on the face in people with acne. Ten adults with oily skin and moderate acne will use the cream twice daily for 3 months. Researchers will take small skin samples to see if the…

This study tests a drug called tildrakizumab in children aged 6 to 17 with moderate-to-severe plaque psoriasis. The goal is to see if it safely reduces skin symptoms like redness and scaling. Participants receive the drug or a placebo, and researchers monitor results over time. S…

This study tests a drug called tildrakizumab against a placebo in 296 adults with active psoriatic arthritis who have never taken anti-TNF medications. The goal is to see if tildrakizumab reduces joint pain and swelling by at least 20%. Participants must have had psoriatic arthri…

This study tests an injected drug called tildrakizumab for people with moderate to severe genital psoriasis. About 206 adults will receive either the drug or a placebo to see if it clears skin and reduces itching. The goal is to improve comfort and quality of life in this sensiti…